ISSN 0303-5212
 

Original Research 


Correlation between dyslipidemia and end-stage liver disease: A public health perspective

Bhagwani, Shakilla Imtiaz Qureshi, Nosheen Aghai, Muhammad Siddique Rajput, Imran Mirbahar, Saqiba Khalil.


Abstract
Objective: To evaluate the abnormal lipid profile and its correlation with end-stage liver disease patients.
Methodology: This cross-sectional study was conducted in the Department of Biochemistry, PUMHSW and the Department of Community Medicine, PMC Hospital, Nawabshah, from July to December 2023. It included 200 CLD patients aged≥20 years of both genders. To assess dyslipidemia patterns, lipid profiles and routine tests were conducted.
Results: Out of 200 patients, 120 (60.0%) were male and 80(40.0%) were female. The mean serum cholesterol level was 165.04±59.63 mg/dl, mean serum triglyceride level was 208.86±137.13 mg/dl, mean serum LDL level was 89.68±19.15 mg/dl, and mean serum HDL level was 40.98±11.19 mg/dl. Severity of disease showed that there were 33 participants in class A, 119 in class B and 48 in class C according to Child Pugh classification. There was statistically significant association between CLD and total cholesterol (p=0.025), and triglycerides (p=0.001). No significant association was observed between CLD and LDL / HDL.
Conclusion: There was a statistically significant association between end-stage liver disease and lipid parameters. Treatment strategy should be focused on complications related to a deranged lipid profile in hospitalized patients with CLD.

Key words: Chronic liver disease, dyslipidemia, lipid parameters.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Bhagwani
Articles by Shakilla Imtiaz Qureshi
Articles by Nosheen Aghai
Articles by Muhammad Siddique Rajput
Articles by Imran Mirbahar
Articles by Saqiba Khalil
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Bhagwani, Qureshi SI, Aghai N, Rajput MS, Mirbahar I, Khalil S. Correlation between dyslipidemia and end-stage liver disease: A public health perspective. RMJ. 2026; 51(1): 28-31.


Web Style

Bhagwani, Qureshi SI, Aghai N, Rajput MS, Mirbahar I, Khalil S. Correlation between dyslipidemia and end-stage liver disease: A public health perspective. https://www.rmj.org.pk/?mno=256840 [Access: February 25, 2026].


AMA (American Medical Association) Style

Bhagwani, Qureshi SI, Aghai N, Rajput MS, Mirbahar I, Khalil S. Correlation between dyslipidemia and end-stage liver disease: A public health perspective. RMJ. 2026; 51(1): 28-31.



Vancouver/ICMJE Style

Bhagwani, Qureshi SI, Aghai N, Rajput MS, Mirbahar I, Khalil S. Correlation between dyslipidemia and end-stage liver disease: A public health perspective. RMJ. (2026), [cited February 25, 2026]; 51(1): 28-31.



Harvard Style

Bhagwani, Qureshi, . S. I., Aghai, . N., Rajput, . M. S., Mirbahar, . I. & Khalil, . S. (2026) Correlation between dyslipidemia and end-stage liver disease: A public health perspective. RMJ, 51 (1), 28-31.



Turabian Style

Bhagwani, Shakilla Imtiaz Qureshi, Nosheen Aghai, Muhammad Siddique Rajput, Imran Mirbahar, and Saqiba Khalil. 2026. Correlation between dyslipidemia and end-stage liver disease: A public health perspective. Rawal Medical Journal, 51 (1), 28-31.



Chicago Style

Bhagwani, Shakilla Imtiaz Qureshi, Nosheen Aghai, Muhammad Siddique Rajput, Imran Mirbahar, and Saqiba Khalil. "Correlation between dyslipidemia and end-stage liver disease: A public health perspective." Rawal Medical Journal 51 (2026), 28-31.



MLA (The Modern Language Association) Style

Bhagwani, Shakilla Imtiaz Qureshi, Nosheen Aghai, Muhammad Siddique Rajput, Imran Mirbahar, and Saqiba Khalil. "Correlation between dyslipidemia and end-stage liver disease: A public health perspective." Rawal Medical Journal 51.1 (2026), 28-31. Print.



APA (American Psychological Association) Style

Bhagwani, Qureshi, . S. I., Aghai, . N., Rajput, . M. S., Mirbahar, . I. & Khalil, . S. (2026) Correlation between dyslipidemia and end-stage liver disease: A public health perspective. Rawal Medical Journal, 51 (1), 28-31.